Table I.
Age interval | ESBL+ KP (n=34) | ESBL- KP (n=41) | P-value | OR (95% CI) |
---|---|---|---|---|
0-20 years | 1 (2.9%) | 5 (12.1%) | 0.0855 | 0.218 (0.024-1.966) |
21-50 years | 3 (8.8%) | 4 (9.7%) | 0.4528 | 0.895 (1.186-4.307) |
51-70 years | 10 (29.4%) | 17 (41.4%) | 0.1464 | 0.588 (0.224-1.543) |
≥71 years | 20 (58.8%) | 15 (36.5%) | 0.0303 | 2.476 (0.974-6.294) |
Mean age | 70.1 | 62.6 | 0.0365 |
All data are expressed as n (%). UTI, urinary tract infections; KB, Klebsiella pneumoniae; ESBL, extended-spectrum β-lactamase; ESBL+ KP, ESBL-producing K. pneumoniae; ESBL- KP, non-ESBL producing KP. OR, odds ratio; CI, confidence interval. Significant P-values are presented in bold print.